Bring the Power
of Foundation
Medicine® and
Roche into Your
Lab.
Introducing the AVENIO Tumor Tissue CGP Kit
Leveraging the FoundationOne® comprehensive
genomic profiling (CGP) secondary analysis platform
and the AVENIO workflow, our kit is part of Roche’s
broad portfolio that offers flexible solutions to meet
your research needs so you can get deeper genomic
insights about solid tumors right in your lab—and
advance discovery.
Learn more at go.roche.com/aveniocgpkit or
contact your local Roche Sequencing representative
for more information.For Research Use Only. Not for use in diagnostic procedures.
AVENIO is a registered trademark of Roche. FOUNDATIONONE is a registered trademark of Foundation
Medicine, Inc. All other product names and trademarks are the property of their respective owners.
© 2022 F. Hoffmann-La Roche Ltd.
MC-US-10498 A674 1/22